Advertisement

Supply Chain



The Senate voted 94-1 to pass a bill that would reauthorize the Food and Drug Administration's program to collect fees for product applications, reports Reuters.

Here are six articles published by Becker's Hospital Review in the last seven days, featuring Express Scripts' addition of 64 drugs to its exclusion list, four thoughts on modernizing the supply chain from a Cardinal Health leader, four factors driving the…

Salt Lake City-based Intermountain Healthcare's adoption of a needle-free blood draw technology caught reader's attention last month.

The Food and Drug Administration on Tuesday approved Celgene Corp.'s cancer drug for use with a companion diagnostic test developed by Abbott Laboratories.

Advertisement

Most Read

Advertisement
Advertisement